[Breast cancer in young women: adjuvant therapy and fertility].
Prognosis of breast cancer women has been dramatically improved by the adjuvant therapies. As the vast majority of patients are cured, the importance of long-term quality of life is growing. The question of the maternity is an essential concern for the young women who have to receive chemotherapy or several years of endocrine therapy. This problem is often underestimated and may lead to emotional distress, depression or anxiety. A regional multidisciplinary working group was set up in order to offer optimal information about fertility and cancer as to propose specific therapeutic reproduction options, when applicable. Specificity of the young patients' breast cancer, the treatment approaches and their impact on fertility are discussed in this paper.
Zaman
K
K
Centre pluridisciplinaire d'oncologie, CHUV, 1011 Lausanne. Khalil.Zaman@chuv.ch
Ambrosetti
A
A
Perey
L
L
Jeanneret-Sozzi
W
W
Delaloye
J F
JF
De Ziegler
D
D
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001943:Breast Neoplasms / Q000150:complications / Q000628:therapy*; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000209:etiology / Q000517:prevention & control
D000970:Antineoplastic Agents